medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2004, Number 3

<< Back Next >>

Rev Biomed 2004; 15 (3)

Congenital toxoplasmosis: a look at the problem

Martín-Hernández I

Language: Spanish
References: 56
Page: 181-190
PDF size: 46.57 Kb.


ABSTRACT

Objectives. This work offers a theoretical and upto-date review of congenital toxoplasmosis, directed not only to medical specialists on this topic, but also to other specialists interested in the study of this disease.
Sources of information. Updated articles and books related to the theme. Internet search.
Results. The parasite Toxoplasma gondii (T. gondii) is one of those responsable for serious congenital infection in newborns, presenting a large number of signs and sequels, even causing death. The risk of congenital transmission and the severity of infection depend on the gestation period in which the pregnant woman is infected. Worldwide, incidence varies from one place to another, between 1:1000 and 1:10000 of live newborns, depending on geographical zone and the socioecomomic levels of the population. Pre and postnatal diagnostic is important by means of serologic searching of specific antibodies or by direct detection of the parasite in order to give early therapy and avoid serious damages to the fetus.
Conclusions. Due to the importance it has for the health of the population, and especially for pregnant women, it is our aim to make tre need of reconsidering a massive screening, starting with a parasitologic exam, continuing to the primary level of health, in order to detect the diagnosis of the primary infection in early pregnancy and make a follow up.


REFERENCES

  1. Botero D, Restrepo M. Toxoplasmosis. En: Botero D, Restrepo M, editores. Parasitosis Humana. 2a ed. Medellín: Corporación para Investigaciones Biológicas; 1992. p 231-48.

  2. Kasper LH. Toxoplasma infection. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrinson’s Principles of Internal Medicine. 15th edition. New York: McGraw-Hill 2001. p. 1222-7.

  3. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. En: Remington JS, Klein JO, editores. Infectious diseases of the fetus and newborn. 5th ed. Philadelphia: WB Saunders; 2001. p 205–346.

  4. Wong SY, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994; 18: 853-62.

  5. Valente P, Sever J. Infecciones congénitas diagnosticadas por muestreo fetal directo. Rev Hosp Niños B Aires 1993; 35: 187-97.

  6. Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. J Infect 1998; 36: 189-96.

  7. Morten L, Larcen SO, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma antibodies in pregnant women in Denmark. Scand J Infect Dis 1993; 25: 751-6.

  8. Lappalainen M, Koskela P, Hedman K, Teramo K, Ammala P, Hiilesmaa V, et al. Incidence of Primary Toxoplasma infections during pregnancy in Southern Finland: A prospective cohort study. Scand J Infect Dis 1992; 24: 97-104.

  9. Lebech M, Larsen SO, Petersen E. Prevalence, incidence, and geografical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Dis 1993; 25: 751-3.

  10. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. Incidence of Toxoplasma gondii infection in 35 940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36: 2900-6.

  11. Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998; 120: 87-92.

  12. Logar J, Novak-Antolic Z, Zore A, Cerar V, Likar M. Incidence of the congenital toxoplasmosis in the Republic of Slovenia. Scand J Infect Dis 1992; 24: 105-8.

  13. Amendoeira MRR, Souza WJS, Paulino AM, Bonifacio AC, Cordeiro JCA, Vicente RT, et al. Toxoplasmosis prevalence and potencial risk of congenital transmission in Rio de Janeiro - Preliminary results. Mem Inst Oswaldo Cruz 1995; 90(Supl 1): 290.

  14. Jones J, López A, Wilson M. Congenital toxoplasmosis. Am Fam Physician 2003; 67: 2131-8.

  15. Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med 2001; 185: 665-83.

  16. Evengard B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Teariaknehjelm K, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001; 127: 121-7.

  17. Mozzatto L, Procianoy RS. Incidence of congenital toxoplasmosis in Southern Brazil: a prospective study. Rev Inst Med Trop Sao Paulo 2003; 45: 147-51.

  18. González T, Molina JR. Toxoplasmosis congénita. Rev Cubana Obstet Ginecol 1997; 23: 7-12.

  19. López R., Pérez X, Guerra E, Herrera R, Acosta C. Toxoplasmosis entre mujeres embarazadas en Ciudad de la Habana. Biomed 1993; 13: 173-8.

  20. González T, Bacallao J, García C, Molina JR. Prevalencia de anticuerpos anti- Toxoplasma gondii en una población de mujeres embarazadas en Cuba. Gac Méd Méx 1991; 131: 499-503.

  21. Acosta C, Pérez X, García R. Presencia de anticuerpos IgG anti- Toxoplasma gondii en embarazadas residentes en Ciudad de la Habana. Rev Biomed 2001; 12: 250-4.

  22. Sánchez A, Martín I, García SM. Estudio de reactividad a Toxoplasma gondii en embarazadas de las provincias Ciudad de la Habana y Pinar del Río, Cuba. Bioquimia 2003; 111: 3-8.

  23. Petersen E, Pollak A, Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol 2001; 31:115–44.

  24. Vergani P. Congenital toxoplasmosis: efficacy of maternal treatment with Spiramycin alone. Am J Reprodu Inmmunol 1998; 39: 335-40.

  25. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271-5.

  26. Crino JP. Ultrasound and fetal diagnosis of perinatal infection. Clin Obstet Gynecol 1999; 42: 71-80.

  27. Machín R,. Bravo JR, Mitjans A, Cordoví R. Toxoplasmosis II. Algunos aspectos relativos a trastornos oculares. Rev. Cub. Med. Trop 1984; 12: 305-14.

  28. Gónzalez I, Díaz M, Pérez J. Coriorretinitis por Toxoplasma en niños. Rev Cubana Med Trop 1999; 51:138-42

  29. Jenum PA, Stray-Pedersen B . Development of specific immunoglobulins G, M and a following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol 1998; 36: 2907-13.

  30. Jenum PA, Holberg-Petersen M, Melby KK, Stray- Pedersen B. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. APMIS 1998; 106: 680-6.

  31. Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990; 28:297-301.

  32. Jenum PA, Stray-Pedersen B, Gudersen A. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of anti-Toxoplasma immunoglobulin G avidity. J Clin Microbiol 1997; 35: 1972-7.

  33. Lappalainen M, Koskela P, Koskiniemi M, Ämmälä P, Hiilesmaa V, Teramo K, et al. Toxoplasmosis acquired during pregnancy improved serodiagnosis based on avidity of IgG. J Infect Dis 1993; 167: 691-7.

  34. Cozon GJ, Ferrandiz J, Nebhi H, Wallon M, Peyron F. Estimation of the avidity of inmunuglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infec Dis 1998; 17: 32-6.

  35. Foudrinier F, Marx-Chemla C, Aubert D, Bonhomme A, Pinon JM. Value of specific immunoglobulin A detection by two immunocapture assay in the diagnosis of toxoplasmosis. Eur J Clin Microbiol Infect Dis 1995; 14: 585-90.

  36. Arcavi M, Orfus G, Griemberg G. Diagnosis of toxoplasmosis by joint of inmunoglobulin A and inmmunoglobulin M. J Clin Microbiol 1997; 35: 1450-3.

  37. Ashburn D, Joss AW, Pennington TH, Ho Yen D. Do IgA, IgE, and IgG avidity test, have any value in the diagnosis of Toxoplasma infection in pregnancy? J Clin Pathol 1998; 51: 312-5.

  38. Gross U, Henkel O, Darde ML. Value of detecting immunoglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection. Clin Diagn Lab Inmunol 1997; 4: 247-51.

  39. Sobieszczanka B., Rdzka A. Detection of IgA antibodies as important markers of acute primary infection with Toxoplasma gondii. Pol Merkuriusz Lek 1997 ; 3: 228-30.

  40. Hohlfeld P, Biedermann K, Extermann P, Gyr T. Toxoplasmosis in pregnancy: Prevention, prenatal diagnosis and treatment. Schweiz Med Wochenschr Suppl 1995; 65: 62-9.

  41. Reis MR. Diagnóstico de la toxoplasmosis congénita. Rev Cubana Invest Biomed 2001; 20: 118-21.

  42. Fricker A, Pelloux H, Muet F, Racinet C, Bost M, Goullier-Fleuret A, et al. Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat Diag 1997; 17: 831-5.

  43. Camargo ME. Alguns aspectos actuais do diagnóstico de laboratório da toxoplasmose. An Acad Nac Med 1995; 155: 236-9.

  44. Holliman RE. Congenital toxoplasmosis: prevention, screening, and treatment. J Hosp Infect 1995; 30: 179-90.

  45. Bader TJ, Macones GA, Aschi DA. Prenatal screening for toxoplasmosis. Obstet Gynecol 1997; 90: 457-64.

  46. Eaton RB. Evaluation of neonatal Toxoplasma gondii IgM FEIA. J Clin Microbiol 1996; 34: 3147-50.

  47. Pinon JM, Chemla C, Villena I, Foudrinier F, Aubert D, Puygauthier-Toubas D, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzymelinked immunofiltration assay immunological profiles and anti- Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol 1996; 34: 579-83.

  48. Newton ER. Diagnosis of perinatal TORCH infections. Clin Obstet Gynecol 1999;42, 59-70.

  49. Guerina NG, Hsu H, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858-963.

  50. Valdés MC, Díaz AG, Svarch N. Actualidades en el tratamiento y profilaxis de la toxoplasmosis. Rev Cubana Med Gen Inegr 1996; 12: 4-6.

  51. Matsui D. Prevention, diagnosis, and treatment of fetal toxoplasmosis. Clin Perinatol 1994; 21: 675-89.

  52. Foulon W, Villena I, Stray P, Decoster A., Lappalainen M., Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmision and children’s sequelate at 1 year. Am J Obstet Gynec 1999; 180 (2 Pt 1): 410-5.

  53. Villena I. Pyrimethamine-Sulfadoxine treatment of congenital toxoplasmosis:follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infec Dis 1998; 30: 295-300.

  54. Kapperud G, Jenum PA, Stray- Pedersen B, Melby KK, Eskild A, Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Am J Epidemiol 1996; 144: 405-12.

  55. Desmonts G. Congenital Toxoplasmosis: A prospective study of 378 pregnancies. N Engl J Med 1974; 290: 1110.

  56. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, McAleese Descombey D, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989; 115: 765-9.




2020     |     www.medigraphic.com